Your browser doesn't support javascript.
loading
The European Medicines Agency review of pitolisant for treatment of narcolepsy: summary of the scientific assessment by the Committee for Medicinal Products for Human Use.
Kollb-Sielecka, Marta; Demolis, Pierre; Emmerich, Joseph; Markey, Greg; Salmonson, Tomas; Haas, Manuel.
Afiliação
  • Kollb-Sielecka M; European Medicines Agency (EMA), London, United Kingdom. Electronic address: marta.kollb-sielecka@ema.europa.
  • Demolis P; European Medicines Agency (EMA), London, United Kingdom; National Agency for the Safety of Medicines and Health Products (ANSM), France.
  • Emmerich J; European Medicines Agency (EMA), London, United Kingdom; National Agency for the Safety of Medicines and Health Products (ANSM), France.
  • Markey G; European Medicines Agency (EMA), London, United Kingdom; Medicines and Healthcare Regulatory Agency (MHRA), London, United Kingdom.
  • Salmonson T; European Medicines Agency (EMA), London, United Kingdom; Läkemedelsverket, Medical Products Agency, Uppsala, Sweden.
  • Haas M; European Medicines Agency (EMA), London, United Kingdom.
Sleep Med ; 33: 125-129, 2017 05.
Article em En | MEDLINE | ID: mdl-28449891

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Piperidinas / Receptores Histamínicos H3 / Narcolepsia Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Adolescent / Adult / Aged / Animals / Humans / Middle aged Idioma: En Revista: Sleep Med Assunto da revista: NEUROLOGIA / PSICOFISIOLOGIA Ano de publicação: 2017 Tipo de documento: Article

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Piperidinas / Receptores Histamínicos H3 / Narcolepsia Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Adolescent / Adult / Aged / Animals / Humans / Middle aged Idioma: En Revista: Sleep Med Assunto da revista: NEUROLOGIA / PSICOFISIOLOGIA Ano de publicação: 2017 Tipo de documento: Article